A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA)

Clinical trial NCT07221669 · RECRUITING

Trial details

NCT number: NCT07221669
Sponsor: Biogen
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Muscular Atrophy, Spinal

Start date: 2026-04-28
Primary completion: 2028-11-28
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.